Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study

Periconceptional folate is essential for proper neurodevelopment. Maternal folic acid intake was examined in relation to the risk of autism spectrum disorder (ASD) and developmental delay (DD). Families enrolled in the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study from 2003 to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of clinical nutrition 2012-07, Vol.96 (1), p.80-89
Hauptverfasser: SCHMIDT, Rebecca J, TANCREDI, Daniel J, OZONOFF, Sally, HANSEN, Robin L, HARTIALA, Jaana, ALLAYEE, Hooman, SCHMIDT, Linda C, TASSONE, Flora, HERTZ-PICCIOTTO, Irva
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 89
container_issue 1
container_start_page 80
container_title The American journal of clinical nutrition
container_volume 96
creator SCHMIDT, Rebecca J
TANCREDI, Daniel J
OZONOFF, Sally
HANSEN, Robin L
HARTIALA, Jaana
ALLAYEE, Hooman
SCHMIDT, Linda C
TASSONE, Flora
HERTZ-PICCIOTTO, Irva
description Periconceptional folate is essential for proper neurodevelopment. Maternal folic acid intake was examined in relation to the risk of autism spectrum disorder (ASD) and developmental delay (DD). Families enrolled in the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study from 2003 to 2009 were included if their child had a diagnosis of ASD (n = 429), DD (n = 130), or typical development (TD; n = 278) confirmed at the University of California Davis Medical Investigation of Neurodevelopmental Disorders Institute by using standardized clinical assessments. Average daily folic acid was quantified for each mother on the basis of dose, brands, and intake frequency of vitamins, supplements, and breakfast cereals reported through structured telephone interviews. Mean (±SEM) folic acid intake was significantly greater for mothers of TD children than for mothers of children with ASD in the first month of pregnancy (P1; 779.0 ± 36.1 and 655.0 ± 28.7 μg, respectively; P < 0.01). A mean daily folic acid intake of ≥600 μg (compared with T variant genotypes. A trend toward an association between lower maternal folic acid intake during the 3 mo before pregnancy and DD was observed, but not after adjustment for confounders. Periconceptional folic acid may reduce ASD risk in those with inefficient folate metabolism. The replication of these findings and investigations of mechanisms involved are warranted.
doi_str_mv 10.3945/ajcn.110.004416
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1021977852</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2695649111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c517t-879b5222ebe0e8b42f1bd204722bbadc77ca95e00bc905738581cc593167eeec3</originalsourceid><addsrcrecordid>eNpdkl2L1DAUhoso7rh67Z0ERFgvupuPtmlvhGEYZ4QVYdHrkCanTmbTpibpwPw8_5npzrh-XIWTPHl4Q94se03wNWuK8kbu1XBN0oRxUZDqSbYgDatzRjF_mi0wxjRvSFVeZC9C2GNMaFFXz7MLSqui5pQssp-fZQQ_SItG8Ea5QcEYjZs3OmeNQlIZjcwQ5T0gOWjkTbhHrkNyiib0KIygop96pE1wXoMPD5SGA1g39pAu2jRZeUwSFHeAVtvl3WaNrlZbY_XOOY2WJ9VdMgfUedejDQwQjTq51sPBeDfMrvdIyQB5ihm9syjESR9fZs86aQO8Oq-X2beP66-rbX77ZfNptbzNVUl4zGvetCWlFFrAULcF7UirKS44pW0rteJcyaYEjFvV4JKzuqyJUmXDSMUBQLHL7MPJO05tD1qlOF5aMXrTS38UThrx78lgduK7OwjGeMFZkQRXZ4F3PyYIUfQmKLBWDuCmIAimpOG8LmlC3_6H7t00_9IDlVKXdckSdXOilHcheOgewxAs5nqIuR4i1UOc6pFuvPn7DY_87z4k4N0ZkEFJ23k5KBP-cBUmTSoU-wVcbce2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1022045853</pqid></control><display><type>article</type><title>Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>SCHMIDT, Rebecca J ; TANCREDI, Daniel J ; OZONOFF, Sally ; HANSEN, Robin L ; HARTIALA, Jaana ; ALLAYEE, Hooman ; SCHMIDT, Linda C ; TASSONE, Flora ; HERTZ-PICCIOTTO, Irva</creator><creatorcontrib>SCHMIDT, Rebecca J ; TANCREDI, Daniel J ; OZONOFF, Sally ; HANSEN, Robin L ; HARTIALA, Jaana ; ALLAYEE, Hooman ; SCHMIDT, Linda C ; TASSONE, Flora ; HERTZ-PICCIOTTO, Irva</creatorcontrib><description>Periconceptional folate is essential for proper neurodevelopment. Maternal folic acid intake was examined in relation to the risk of autism spectrum disorder (ASD) and developmental delay (DD). Families enrolled in the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study from 2003 to 2009 were included if their child had a diagnosis of ASD (n = 429), DD (n = 130), or typical development (TD; n = 278) confirmed at the University of California Davis Medical Investigation of Neurodevelopmental Disorders Institute by using standardized clinical assessments. Average daily folic acid was quantified for each mother on the basis of dose, brands, and intake frequency of vitamins, supplements, and breakfast cereals reported through structured telephone interviews. Mean (±SEM) folic acid intake was significantly greater for mothers of TD children than for mothers of children with ASD in the first month of pregnancy (P1; 779.0 ± 36.1 and 655.0 ± 28.7 μg, respectively; P &lt; 0.01). A mean daily folic acid intake of ≥600 μg (compared with &lt;600 μg) during P1 was associated with reduced ASD risk (adjusted OR: 0.62; 95% CI: 0.42, 0.92; P = 0.02), and risk estimates decreased with increased folic acid (P-trend = 0.001). The association between folic acid and reduced ASD risk was strongest for mothers and children with MTHFR 677 C&gt;T variant genotypes. A trend toward an association between lower maternal folic acid intake during the 3 mo before pregnancy and DD was observed, but not after adjustment for confounders. Periconceptional folic acid may reduce ASD risk in those with inefficient folate metabolism. The replication of these findings and investigations of mechanisms involved are warranted.</description><identifier>ISSN: 0002-9165</identifier><identifier>EISSN: 1938-3207</identifier><identifier>DOI: 10.3945/ajcn.110.004416</identifier><identifier>PMID: 22648721</identifier><identifier>CODEN: AJCNAC</identifier><language>eng</language><publisher>Bethesda, MD: American Society for Nutrition</publisher><subject>Autism ; Biological and medical sciences ; California - epidemiology ; Case-Control Studies ; Child Development Disorders, Pervasive - epidemiology ; Child Development Disorders, Pervasive - etiology ; Child Development Disorders, Pervasive - genetics ; Child, Preschool ; Confounding Factors, Epidemiologic ; Developmental Disabilities - epidemiology ; Developmental Disabilities - etiology ; Developmental Disabilities - genetics ; Diet - adverse effects ; Dietary Supplements - analysis ; Feeding. Feeding behavior ; Female ; Folic Acid - administration &amp; dosage ; Folic Acid Deficiency - physiopathology ; Food, Fortified - analysis ; Fundamental and applied biological sciences. Psychology ; Genetic Association Studies ; Growth, Development, and Pediatrics ; Humans ; Infant ; Male ; Maternal &amp; child health ; Maternal Nutritional Physiological Phenomena ; Metabolism ; Methylenetetrahydrofolate Reductase (NADPH2) - genetics ; Methylenetetrahydrofolate Reductase (NADPH2) - metabolism ; Nutrition ; Polymorphism, Single Nucleotide ; Pregnancy ; Pregnancy Complications - physiopathology ; Pregnancy Trimester, First ; Risk ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; Vitamin B</subject><ispartof>The American journal of clinical nutrition, 2012-07, Vol.96 (1), p.80-89</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright American Society for Clinical Nutrition, Inc. Jul 1, 2012</rights><rights>2012 American Society for Nutrition 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c517t-879b5222ebe0e8b42f1bd204722bbadc77ca95e00bc905738581cc593167eeec3</citedby><cites>FETCH-LOGICAL-c517t-879b5222ebe0e8b42f1bd204722bbadc77ca95e00bc905738581cc593167eeec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26019916$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22648721$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCHMIDT, Rebecca J</creatorcontrib><creatorcontrib>TANCREDI, Daniel J</creatorcontrib><creatorcontrib>OZONOFF, Sally</creatorcontrib><creatorcontrib>HANSEN, Robin L</creatorcontrib><creatorcontrib>HARTIALA, Jaana</creatorcontrib><creatorcontrib>ALLAYEE, Hooman</creatorcontrib><creatorcontrib>SCHMIDT, Linda C</creatorcontrib><creatorcontrib>TASSONE, Flora</creatorcontrib><creatorcontrib>HERTZ-PICCIOTTO, Irva</creatorcontrib><title>Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study</title><title>The American journal of clinical nutrition</title><addtitle>Am J Clin Nutr</addtitle><description>Periconceptional folate is essential for proper neurodevelopment. Maternal folic acid intake was examined in relation to the risk of autism spectrum disorder (ASD) and developmental delay (DD). Families enrolled in the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study from 2003 to 2009 were included if their child had a diagnosis of ASD (n = 429), DD (n = 130), or typical development (TD; n = 278) confirmed at the University of California Davis Medical Investigation of Neurodevelopmental Disorders Institute by using standardized clinical assessments. Average daily folic acid was quantified for each mother on the basis of dose, brands, and intake frequency of vitamins, supplements, and breakfast cereals reported through structured telephone interviews. Mean (±SEM) folic acid intake was significantly greater for mothers of TD children than for mothers of children with ASD in the first month of pregnancy (P1; 779.0 ± 36.1 and 655.0 ± 28.7 μg, respectively; P &lt; 0.01). A mean daily folic acid intake of ≥600 μg (compared with &lt;600 μg) during P1 was associated with reduced ASD risk (adjusted OR: 0.62; 95% CI: 0.42, 0.92; P = 0.02), and risk estimates decreased with increased folic acid (P-trend = 0.001). The association between folic acid and reduced ASD risk was strongest for mothers and children with MTHFR 677 C&gt;T variant genotypes. A trend toward an association between lower maternal folic acid intake during the 3 mo before pregnancy and DD was observed, but not after adjustment for confounders. Periconceptional folic acid may reduce ASD risk in those with inefficient folate metabolism. The replication of these findings and investigations of mechanisms involved are warranted.</description><subject>Autism</subject><subject>Biological and medical sciences</subject><subject>California - epidemiology</subject><subject>Case-Control Studies</subject><subject>Child Development Disorders, Pervasive - epidemiology</subject><subject>Child Development Disorders, Pervasive - etiology</subject><subject>Child Development Disorders, Pervasive - genetics</subject><subject>Child, Preschool</subject><subject>Confounding Factors, Epidemiologic</subject><subject>Developmental Disabilities - epidemiology</subject><subject>Developmental Disabilities - etiology</subject><subject>Developmental Disabilities - genetics</subject><subject>Diet - adverse effects</subject><subject>Dietary Supplements - analysis</subject><subject>Feeding. Feeding behavior</subject><subject>Female</subject><subject>Folic Acid - administration &amp; dosage</subject><subject>Folic Acid Deficiency - physiopathology</subject><subject>Food, Fortified - analysis</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetic Association Studies</subject><subject>Growth, Development, and Pediatrics</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Maternal &amp; child health</subject><subject>Maternal Nutritional Physiological Phenomena</subject><subject>Metabolism</subject><subject>Methylenetetrahydrofolate Reductase (NADPH2) - genetics</subject><subject>Methylenetetrahydrofolate Reductase (NADPH2) - metabolism</subject><subject>Nutrition</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - physiopathology</subject><subject>Pregnancy Trimester, First</subject><subject>Risk</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><subject>Vitamin B</subject><issn>0002-9165</issn><issn>1938-3207</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkl2L1DAUhoso7rh67Z0ERFgvupuPtmlvhGEYZ4QVYdHrkCanTmbTpibpwPw8_5npzrh-XIWTPHl4Q94se03wNWuK8kbu1XBN0oRxUZDqSbYgDatzRjF_mi0wxjRvSFVeZC9C2GNMaFFXz7MLSqui5pQssp-fZQQ_SItG8Ea5QcEYjZs3OmeNQlIZjcwQ5T0gOWjkTbhHrkNyiib0KIygop96pE1wXoMPD5SGA1g39pAu2jRZeUwSFHeAVtvl3WaNrlZbY_XOOY2WJ9VdMgfUedejDQwQjTq51sPBeDfMrvdIyQB5ihm9syjESR9fZs86aQO8Oq-X2beP66-rbX77ZfNptbzNVUl4zGvetCWlFFrAULcF7UirKS44pW0rteJcyaYEjFvV4JKzuqyJUmXDSMUBQLHL7MPJO05tD1qlOF5aMXrTS38UThrx78lgduK7OwjGeMFZkQRXZ4F3PyYIUfQmKLBWDuCmIAimpOG8LmlC3_6H7t00_9IDlVKXdckSdXOilHcheOgewxAs5nqIuR4i1UOc6pFuvPn7DY_87z4k4N0ZkEFJ23k5KBP-cBUmTSoU-wVcbce2</recordid><startdate>20120701</startdate><enddate>20120701</enddate><creator>SCHMIDT, Rebecca J</creator><creator>TANCREDI, Daniel J</creator><creator>OZONOFF, Sally</creator><creator>HANSEN, Robin L</creator><creator>HARTIALA, Jaana</creator><creator>ALLAYEE, Hooman</creator><creator>SCHMIDT, Linda C</creator><creator>TASSONE, Flora</creator><creator>HERTZ-PICCIOTTO, Irva</creator><general>American Society for Nutrition</general><general>American Society for Clinical Nutrition, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T7</scope><scope>7TS</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20120701</creationdate><title>Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study</title><author>SCHMIDT, Rebecca J ; TANCREDI, Daniel J ; OZONOFF, Sally ; HANSEN, Robin L ; HARTIALA, Jaana ; ALLAYEE, Hooman ; SCHMIDT, Linda C ; TASSONE, Flora ; HERTZ-PICCIOTTO, Irva</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c517t-879b5222ebe0e8b42f1bd204722bbadc77ca95e00bc905738581cc593167eeec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Autism</topic><topic>Biological and medical sciences</topic><topic>California - epidemiology</topic><topic>Case-Control Studies</topic><topic>Child Development Disorders, Pervasive - epidemiology</topic><topic>Child Development Disorders, Pervasive - etiology</topic><topic>Child Development Disorders, Pervasive - genetics</topic><topic>Child, Preschool</topic><topic>Confounding Factors, Epidemiologic</topic><topic>Developmental Disabilities - epidemiology</topic><topic>Developmental Disabilities - etiology</topic><topic>Developmental Disabilities - genetics</topic><topic>Diet - adverse effects</topic><topic>Dietary Supplements - analysis</topic><topic>Feeding. Feeding behavior</topic><topic>Female</topic><topic>Folic Acid - administration &amp; dosage</topic><topic>Folic Acid Deficiency - physiopathology</topic><topic>Food, Fortified - analysis</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetic Association Studies</topic><topic>Growth, Development, and Pediatrics</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Maternal &amp; child health</topic><topic>Maternal Nutritional Physiological Phenomena</topic><topic>Metabolism</topic><topic>Methylenetetrahydrofolate Reductase (NADPH2) - genetics</topic><topic>Methylenetetrahydrofolate Reductase (NADPH2) - metabolism</topic><topic>Nutrition</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - physiopathology</topic><topic>Pregnancy Trimester, First</topic><topic>Risk</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><topic>Vitamin B</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCHMIDT, Rebecca J</creatorcontrib><creatorcontrib>TANCREDI, Daniel J</creatorcontrib><creatorcontrib>OZONOFF, Sally</creatorcontrib><creatorcontrib>HANSEN, Robin L</creatorcontrib><creatorcontrib>HARTIALA, Jaana</creatorcontrib><creatorcontrib>ALLAYEE, Hooman</creatorcontrib><creatorcontrib>SCHMIDT, Linda C</creatorcontrib><creatorcontrib>TASSONE, Flora</creatorcontrib><creatorcontrib>HERTZ-PICCIOTTO, Irva</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of clinical nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCHMIDT, Rebecca J</au><au>TANCREDI, Daniel J</au><au>OZONOFF, Sally</au><au>HANSEN, Robin L</au><au>HARTIALA, Jaana</au><au>ALLAYEE, Hooman</au><au>SCHMIDT, Linda C</au><au>TASSONE, Flora</au><au>HERTZ-PICCIOTTO, Irva</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study</atitle><jtitle>The American journal of clinical nutrition</jtitle><addtitle>Am J Clin Nutr</addtitle><date>2012-07-01</date><risdate>2012</risdate><volume>96</volume><issue>1</issue><spage>80</spage><epage>89</epage><pages>80-89</pages><issn>0002-9165</issn><eissn>1938-3207</eissn><coden>AJCNAC</coden><abstract>Periconceptional folate is essential for proper neurodevelopment. Maternal folic acid intake was examined in relation to the risk of autism spectrum disorder (ASD) and developmental delay (DD). Families enrolled in the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study from 2003 to 2009 were included if their child had a diagnosis of ASD (n = 429), DD (n = 130), or typical development (TD; n = 278) confirmed at the University of California Davis Medical Investigation of Neurodevelopmental Disorders Institute by using standardized clinical assessments. Average daily folic acid was quantified for each mother on the basis of dose, brands, and intake frequency of vitamins, supplements, and breakfast cereals reported through structured telephone interviews. Mean (±SEM) folic acid intake was significantly greater for mothers of TD children than for mothers of children with ASD in the first month of pregnancy (P1; 779.0 ± 36.1 and 655.0 ± 28.7 μg, respectively; P &lt; 0.01). A mean daily folic acid intake of ≥600 μg (compared with &lt;600 μg) during P1 was associated with reduced ASD risk (adjusted OR: 0.62; 95% CI: 0.42, 0.92; P = 0.02), and risk estimates decreased with increased folic acid (P-trend = 0.001). The association between folic acid and reduced ASD risk was strongest for mothers and children with MTHFR 677 C&gt;T variant genotypes. A trend toward an association between lower maternal folic acid intake during the 3 mo before pregnancy and DD was observed, but not after adjustment for confounders. Periconceptional folic acid may reduce ASD risk in those with inefficient folate metabolism. The replication of these findings and investigations of mechanisms involved are warranted.</abstract><cop>Bethesda, MD</cop><pub>American Society for Nutrition</pub><pmid>22648721</pmid><doi>10.3945/ajcn.110.004416</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9165
ispartof The American journal of clinical nutrition, 2012-07, Vol.96 (1), p.80-89
issn 0002-9165
1938-3207
language eng
recordid cdi_proquest_miscellaneous_1021977852
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Autism
Biological and medical sciences
California - epidemiology
Case-Control Studies
Child Development Disorders, Pervasive - epidemiology
Child Development Disorders, Pervasive - etiology
Child Development Disorders, Pervasive - genetics
Child, Preschool
Confounding Factors, Epidemiologic
Developmental Disabilities - epidemiology
Developmental Disabilities - etiology
Developmental Disabilities - genetics
Diet - adverse effects
Dietary Supplements - analysis
Feeding. Feeding behavior
Female
Folic Acid - administration & dosage
Folic Acid Deficiency - physiopathology
Food, Fortified - analysis
Fundamental and applied biological sciences. Psychology
Genetic Association Studies
Growth, Development, and Pediatrics
Humans
Infant
Male
Maternal & child health
Maternal Nutritional Physiological Phenomena
Metabolism
Methylenetetrahydrofolate Reductase (NADPH2) - genetics
Methylenetetrahydrofolate Reductase (NADPH2) - metabolism
Nutrition
Polymorphism, Single Nucleotide
Pregnancy
Pregnancy Complications - physiopathology
Pregnancy Trimester, First
Risk
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Vitamin B
title Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T03%3A31%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Maternal%20periconceptional%20folic%20acid%20intake%20and%20risk%20of%20autism%20spectrum%20disorders%20and%20developmental%20delay%20in%20the%20CHARGE%20(CHildhood%20Autism%20Risks%20from%20Genetics%20and%20Environment)%20case-control%20study&rft.jtitle=The%20American%20journal%20of%20clinical%20nutrition&rft.au=SCHMIDT,%20Rebecca%20J&rft.date=2012-07-01&rft.volume=96&rft.issue=1&rft.spage=80&rft.epage=89&rft.pages=80-89&rft.issn=0002-9165&rft.eissn=1938-3207&rft.coden=AJCNAC&rft_id=info:doi/10.3945/ajcn.110.004416&rft_dat=%3Cproquest_pubme%3E2695649111%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1022045853&rft_id=info:pmid/22648721&rfr_iscdi=true